Our Prostate Cancer community was happy when Bayer and Algeta announced an Early/Expanded Access Program for Alpharedin. However we notice that, as of today, there is only one clinical trial site that is currently open and taking any new patients. However, this site is limited to only 2 men per month and their waiting list almost goes into the next calendar year!
Men who are experiencing excruciating pain could be receiving pain relief and the opportunity for extended life with early access to Alpharadin.
We ask that Bayer and Algeta put their Early/Expanded Access Program as announced into action, today. Open the sites that have been listed, add more sites and remove the caps from the sites.
Please join Malecare in contacting the following individuals and ask;
“Please make Alpharedin available today to men with advanced stage prostate cancer.
Send an email today and let them know we need Alpharadin NOW.
2- Mike Booth; Algeta Communications & Corporate Affairs; firstname.lastname@example.org
3- Mark Swallow; Algeta International Media Inquiries; Citigate Dewe Rogerson; email@example.com
Joel T Nowak, M.A., M.S.W.
I’ve been in contact with Mass. General where I paticipated in XL184 trial last year into this year for 6+months–David Emerson was also in the same trial. Was told they expect to have radium 223(Alpharadin) this October….a few weeks ago (dreading the drive back & forth to Boston) I called Sloan-Kettering in NYC, the Government clinical trial site said they were recruiting for ‘A Study of Alpharadin® With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)’ turns out it was full, so I asked if they were going to have Alpharadin in itself in Oct like Mass. General–even though Sloan or NYC was not listed as one of the citys that would have alpharadium as stated in Gov. site–
their reply to me was YES–she told me all sites that were expecting Alpharadin…were expecting the Expanded access progam to start across the nation in Oct. Take this info for what it’s worth….FWIW–who knows? But this is the info I was given.
The good news for me is…… I thought Zytega had stopped working for me but my PSA after going down for 3-4 months/ and then went up (this is why I started to look at Alpharanin–thought Zytega was no longer working)my PSA went down again in Aug.—Soooo I’m no longer Eligibile for Alpharadin since Zytega is working for me.
I have bone mets and a rising PSA and need Alpharadin NOW. Please let the trials continue. There are many others like myself who need it. To withhold it further is cruel. If there is some life threatning reason for with holding it please let us know.
The bottom line is that Zytiga is working for you, that is the best news of the month.
As far as the future of Alpharadin and early access, we will have to wait and see. They have supposedly opened a new site at Moffitt Hospital in Florida, but the site in Las Vegas remains limited to just two men a month and the site in Louisiana is still struggling to process men.
Some of us on the Early Access Committee continue to work with Bayer with the hope that we can get them to meet their initial commitments.
Read some where that other states have been added for trial access.
One of which is New York….try to find URL..can you help.
Ken, For a complete current list (not including the New ork site) go to my post at: http://advancedprostatecancer.net/?p=3521